Product Categories

p38 MAPK p38 Mitogen-activated Protein Kinase

  • Compare p38 MAPK Inhibitors
  • Research Area

p38 MAPK Inhibitors (9)

water-soluble

Cat.No. Product Name Information Product Citations Customer Reviews
S1076 SB 203580 SB203580 is a p38 MAPK inhibitor with IC50 of 0.3-0.5 μM and blocks PKB phosphorylation with IC50 of 3-5 μM.
S1574 BIRB 796 (Doramapimod) BIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM.
S1077 SB 202190 SB 202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38α and p38β with IC50 of 50 nM and 100 nM, respectively.
S1494 LY2228820 LY2228820 is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM.
S6005 VX-702 VX-702 is a highly selective inhibitor of p38 MAPKα with IC50 of 4-20 nM.
S1527 Vinorelbine (Navelbine) Vinorelbine (Navelbine) is an anti-mitotic agent which inhibits the proliferation of Hela cells with IC50 of 1.25 nM.
S2726 PH-797804 PH-797804 is a novel pyridinone inhibitor of p38α with IC50 of 26 nM.
S1458 VX-745 VX-745 is a potent and selective inhibitor of p38α MAPK and p38β MAPK with IC50 of 10 nM and 220 nM, respectively.
S2928 TAK 715 TAK 715 is a p38 MAPK inhibitor for p38α with IC50 of 7.1 nM.
Page:
  • 1
All p38 MAPK Inhibitors
Tags: p38 MAPK activation | p38 MAPK pathway | p38 protein kinase | p38 MAPK signaling | p38 MAP Kinase pathway | p38 MAPK activity | p38 MAPK phosphorylation | p38 MAPK apoptosis | p38 MAPK signaling pathway | p38 MAPK cancer | p38 kinase assay | p38 inhibitors clinical trials | p38 MAPK assay | p38 MAPK inhibitors clinical trials | p38 MAPK inhibitor review